Bio-IT World is announcing its 2010 Best Practices awards program and is opening the call for entries. Established in 2003, this prestigious awards program is designed to recognize outstanding examples of technology and strategic innovation--initiatives and collaborations that manifestly improve some facet of the R&D/drug development/clinical trial process.
Needham, MA (PRWEB) October 8, 2009 -- Bio-IT World is announcing its 2010 Best Practices awards program and is opening the call for entries. Established in 2003, this prestigious awards program is designed to recognize outstanding examples of technology and strategic innovation--initiatives and collaborations that manifestly improve some facet of the R&D/drug development/clinical trial process.
The deadline for entry in the program is January 18, 2010 with an early bird deadline of December 18, 2009.
The awards attract an elite group of life science professionals: executives, entrepreneurs, innovators, researchers and clinicians responsible for developing and implementing innovative solutions for streamlining the drug development and clinical trial process. Bio-IT World's distinguished peer-review panel of judges has reviewed almost 400 entries in the program's history, with last year's 70+ entries and 10 awards breaking all previous records.
"These awards spotlight examples of the most outstanding innovations, technologies and practices in the fields of biomedical research, drug development and clinical research--spotlighting the tools and strategies that can make a difference in the conduct of basic and clinical research, speeding the drug discovery pipeline, and changing the way we generate, share and analyze data and knowledge," says Kevin Davies, editor-in-chief, Bio-IT World.
Winners last year included Merck, Abbott Laboratories, National Center for Genome Resources, Children's Hospital of Philadelphia, Amgen, the Broad Institute, GlaxoSmithKline, Vanderbilt University, Wyeth, Genentech, and AstraZeneca and were featured in the July/August 2009 issue of Bio-IT World.
Entries will be accepted in nine categories: Basic Research & Biological Research; Drug Discovery & Development; Clinical Trials & Research; Translational Medicine; Personalized Medicine; IT & Informatics; Knowledge Management; Health-IT; and Manufacturing & Bioprocessing.
The 2010 winners will receive a unique crystal award to be presented at the Best Practices Awards dinner on Wednesday, April 21, 2010, in conjunction with the Bio-IT World Conference & Expo in Boston. The 7 track event is designed to be highly interactive with lectures, panel discussions, and various receptions as a way to facilitate networking opportunities and hear differing views and perspectives on poignant issues facing the industry today.
For more information on the program and to download the entry form, please visit www.bio-itworld.com/bestpractices.
For more information on the 2010 Bio-IT World Conference & Expo, please visit www.bio-itworldexpo.com.
Managing Editor, Bio-IT World
aproffitt (at) healthtech (dot) com
ABOUT BIO-IT WORLD
Bio-IT World (www.bio-itworld.com), the flagship publication of Cambridge Healthtech Institute (CHI), is the leading source of news on technology and strategic innovation in drug discovery, development, and clinical trials. Bio-IT World explores the tools and results of predictive biology as the industry adapts to the new world of personalized medicine.
Bio-IT World has won 34 national and regional awards, more than any other magazine covering the life sciences industry. Bio-IT World was acquired by CHI in 2006 and is part of the Cambridge Healthtech Media Group that offers a suite of published resources that include Bio-IT World magazine, numerous topic-specific eNewsletters, white papers, webcasts, podcasts, conferences, and the Bio-IT World Best Practices Awards. Established in 2001, the magazine is based in Needham, Mass.
About Cambridge Healthtech Institute (CHI)
Founded in 1992, Cambridge Healthtech Institute (CHI) -- www.chicorporate.com -- strives to develop quality information resources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments in the life sciences industry. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage of the strategy behind the business.
CHI is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech, CROs, academia, and niche service providers. CHI is renowned for its vast conference portfolio--500 conferences held worldwide--and offers a fully integrated life sciences portfolio of products, services, educational programs, analytical research reports, management consulting services, multi-media solutions, and publications including Bio-IT World. For a comprehensive listing and detailed information, visit www.chicorporate.com .
Read the full story at http://www.prweb.com/releases/2009/10/prweb3015344.htm.
Copyright©2009 Vocus, Inc.
All rights reserved